Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

NCT00679588 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4413

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Semuloparin Sodium
DRUG: Enoxaparin sodium
DRUG: Placebo

Sponsor

Sanofi